Sources | Names Used |
---|---|
CTRPv2 | selumetinib:UNC0638 (4:1 mol/mol) |
PharmacoGx | selumetinib:UNC0638 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HNMT | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
mRNA | ADGRE5 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
mRNA | YEATS2 | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-07 |
mRNA | PHLPP2 | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-07 |
mRNA | SLC22A18 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
mRNA | ERBB3 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-07 |
mRNA | CCDC117 | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-07 |
mRNA | ASF1B | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-07 |
mRNA | SGO1 | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-07 |
mRNA | LAD1 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-07 |